CareRx Corporation
TSX:CRRX.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $203.06M
- Beta
- 0.62
- P/E (TTM)
- 7.4
- EPS (TTM)
- $0.43
- Dividend yield
- 1.88%
Volume 0.01M
Average 0.04M
CRRX.TO Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
CareRx CorporationTSX: CRRX.TO
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables rises 2.9% from a year ago
Net receivables stood at CA$33.46M at the end of Q1 FY2026, up 2.9% from a year earlier and up 1.7% from the prior quarter. Over 3 fiscal years it compounded at -4.1% a year.
Context
- Net receivables amounted to 13.4% of total assets at the end of Q1 FY2026, down 1.1 pp from a year earlier.
- Net receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +2.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
CAD · from the balance sheet
- Latest · FY2025
- 32.9M CAD
- Year-over-year change
- -0.7%
- 4-year CAGR
- -3.6%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.9M | -0.7% |
| FY2024 | 2024-12-31 | 33.15M | -8.2% |
| FY2023 | 2023-12-31 | 36.09M | -3.1% |
| FY2022 | 2022-12-31 | 37.26M | -2.2% |
| FY2021 | 2021-12-31 | 38.11M | — |
Net Receivables vs competitors
How CRRX.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +2.9% is the 3rd highest of 6, against a peer median of -6.5%.
- Net receivables amounts to 13.4% of total assets for CRRX.TO, versus a peer median of 7.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$33.46M CAD | +2.9% | -4.1% | 13.4% | |
| Mar 2026 | $33.17M USD | -24.8% | -18.3% | 11.9% | |
| Mar 2026 | CA$21.12M CAD | -6.5% | +8.5% | 7.6% | |
PRN.TOProfound Medical Corp. | Mar 2026 | $9.43M USD | +58.1% | -3.8% | 12.8% |
| Mar 2026 | $8.14M USD | +16.6% | -11.2% | 6.2% | |
| Apr 2026 | CA$28K CAD | -90.2% | -24.3% | 0.1% | |
| Peer median (excluding CRRX.TO) | — | -6.5% | -11.2% | 7.6% | |
Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 35.63M | 28.37M | 7.03M | 9.08M | 14.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 38.11M | 37.26M | 36.09M | 33.15M | 32.9M |
| Inventory | 17.99M | 20.3M | 19.66M | 17.67M | 17.55M |
| Other Current Assets | 680K | 3.24M | 1.96M | 2.43M | 2.17M |
| Total Current Assets | 95.25M | 89.18M | 65.41M | 62.34M | 67.02M |
| Property, Plant & Equipment (Net) | 38.17M | 52.39M | 52.14M | 56.89M | 54.26M |
| Goodwill | 92.12M | 70.01M | 70.01M | 70.01M | 70.01M |
| Intangible Assets | 54.57M | 52.96M | 44.33M | 34.3M | 28.89M |
| Long-term Investments | 2.71M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 32.85M |
| Other Non-current Assets | (187.57M) | (175.36M) | 0 | 0 | 0 |
| Total Non-current Assets | 187.57M | 175.36M | 166.48M | 161.2M | 186M |
| Total Assets | 282.82M | 264.54M | 231.89M | 223.54M | 253.02M |
| Account Payables | 33.21M | 30.48M | 29.11M | 31.83M | 33.89M |
| Short-term Debt | 733K | 7.41M | 9.92M | 5.33M | 7.87M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 13.11M | 0 | (125K) | 822K | 758K |
| Other Current Liabilities | 9.95M | 5.84M | 2.19M | 1.32M | 3.94M |
| Total Current Liabilities | 52.97M | 63.89M | 62.45M | 62.8M | 63.03M |
| Long-term Debt | 111.97M | 99.37M | 57.15M | 39.96M | 35.96M |
| Deferred Tax Liabilities | 5.46M | 4.01M | 0 | 0 | 10.07M |
| Deferred Revenue (Non-current) | 15.16M | 3.23M | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.63M | 3.73M | 2.77M | 2M | 354K |
| Total Non-current Liabilities | 147.56M | 136.19M | 87.92M | 76.51M | 80.48M |
| Total Liabilities | 200.53M | 200.08M | 150.37M | 139.31M | 143.51M |
| Common Stock | 283.46M | 299.78M | 323.3M | 331.11M | 332.49M |
| Retained Earnings | (242.93M) | (277.28M) | (282.69M) | (287.19M) | (263.58M) |
| Accumulated OCI | 9.43M | 7.46M | 7.3M | 583K | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 82.29M | 64.46M | 81.53M | 84.23M | 109.5M |
| Total Debt | 125.57M | 135.22M | 97.86M | 82.63M | 77.93M |
| Net Debt | 89.95M | 106.85M | 90.84M | 73.55M | 63.53M |
CareRx Corporation
TSX:CRRX.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.